Page 44 - Anjali Singh

Car leasing player Avyens eyes 8-10 per cent fleet growth in 2024

Indian car leasing market comprises of approximately 90,000 vehicles. Projection of Ayvens aligns with rising trend of car leasing as businesses seek more flexible & cost-effective mobility solutions

Wales and Maharashtra explore collaboration on Future Generations Act

The visit of MLAs to Wales last year ignited interest as Wales delved into the intricacies of the Wellbeing of Future Generations Act

Major hospital chains report increase in average revenue per occupied bed

The increase in ARPOB comes despite significant bed additions by hospitals in the past two financial years

Electric vehicles set to corner a third of Volvo Car India's 2024 sales

Volvo has also officially confirmed its plans to introduce two additional electric vehicles in the Indian market by 2025

Digital lab at fingertips: Neodocs aims to perform 100 mn tests in 3 years

The company employs diagnostic laboratory (lab) principles through a smartphone application (app) and a test card

Cipla receives approval from drug regulator CDSCO for UTI drug

Plazomicin is a new intravenous (IV) aminoglycoside that has demonstrated efficacy and safety in clinical trials compared to meropenem (antibacterial agent)

Pfizer, Niper collaborate to support healthcare startups in India

The Pfizer INDovation initiative, which has supported 34 startups in India till now, is now expanding its reach through this collaboration with NIPER Ahmedabad

7 in 10 Indians opt for nutraceuticals; most don't consult doctors: Survey

The survey by LocalCircles also highlighted that 68 per cent of nutraceutical users buy them from local medical or general stores

Amended surrogacy law likely to boost market potential, say experts

The Centre on Wednesday amended the Surrogacy (Regulation) Act 2021, effecting a change that comes after years of debate and advocacy and likely to benefit couples struggling with infertility

JSW Group, Volkswagen begin talks to set up electric vehicle joint venture

Talks with JSW came within days of the German carmaker announcing it would supply components for EVs and battery cells to Mahindra & Mahindra

GPT Healthcare sets price band at Rs 177-188 for IPO opening on Feb 22

The company revealed the price band for its upcoming initial public offering (IPO), set at Rs 177 to 188 per share

Meril Life Sciences eyes 5-fold revenue growth over the next 5 years

Currently, 55 per cent of Meril's revenue comes from its international business, through its presence in over 150 countries and subsidiaries in more than 25 nations such as Germany, Russia and Brazil

Tier-II cities see surge in medical consultations, outpacing metros: Report

Metro cities also experienced a surge in medical consultations, with Mumbai leading at 92.07 per cent, followed by Hyderabad at 91.63 per cent and Chennai at 83.4 per cent

Utkarsh Small Finance Bank proposes reverse merger with holding entity

The bank has said it has taken note of the proposal and the Board of Directors of the lender will meet in due course and evaluate the proposal and other options to achieve regulatory compliance

Medical groups raise concerns around India-EFTA after leaked documents

Doctors Without Borders (MSF), Public Eye, and Delhi Network of Positive People expressed concern that the deal, which is nearing completion, includes harmful intellectual property (IP) proposals

Glenmark Pharma Q3 results: Standalone loss at Rs 20 cr, revenue dips 38.4%

Glenmark is going through a transitionary phase on account of divestment of Glenmark Life Sciences, says MD

Eris Lifesciences Q3 results: Profit flat at Rs 102 crore, revenue up 16%

On a sequential basis, the company saw a 3.40 per cent decline in revenue along with Profit After Tax (PAT), which also declined by 16.77 per cent

India witnesses decline in vector-borne tropical diseases in last 2 years

NCVBDC numbers reveal a downward trend in these diseases over the past few years, indicating successful control efforts

Dr Reddy's Laboratories R&D facility gets VAI status in USFDA inspection

Last year in December, during the Good Manufacturing Practice (GMP) and Pre-Approval Inspection at the same facility concluded with three observations

MRF Q3 results: PAT rises threefold to Rs 509 crore, revenue up 9.17%

The company opted not to disclose figures for its international operations, citing their insignificance in meeting the disclosure threshold specified in the Indian Accounting Standards